4531 Stock Overview
Researches, develops, manufactures, and markets fine chemical products in Japan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
Yuki Gosei Kogyo Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥269.00 |
| 52 Week High | JP¥359.00 |
| 52 Week Low | JP¥240.00 |
| Beta | 0.65 |
| 11 Month Change | 2.28% |
| 3 Month Change | -11.80% |
| 1 Year Change | -7.24% |
| 33 Year Change | -17.48% |
| 5 Year Change | 14.47% |
| Change since IPO | -61.57% |
Recent News & Updates
Shareholder Returns
| 4531 | JP Chemicals | JP Market | |
|---|---|---|---|
| 7D | -0.4% | 0.9% | 1.0% |
| 1Y | -7.2% | 19.0% | 14.2% |
Return vs Industry: 4531 underperformed the JP Chemicals industry which returned 19% over the past year.
Return vs Market: 4531 underperformed the JP Market which returned 14.2% over the past year.
Price Volatility
| 4531 volatility | |
|---|---|
| 4531 Average Weekly Movement | 6.3% |
| Chemicals Industry Average Movement | 6.4% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in JP Market | 10.4% |
| 10% least volatile stocks in JP Market | 3.5% |
Stable Share Price: 4531 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4531's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1947 | 290 | Seiichiro Matsumoto | www.yuki-gosei.co.jp |
Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients.
Yuki Gosei Kogyo Co., Ltd. Fundamentals Summary
| 4531 fundamental statistics | |
|---|---|
| Market cap | JP¥5.82b |
| Earnings (TTM) | JP¥828.00m |
| Revenue (TTM) | JP¥13.25b |
7.0x
P/E Ratio0.4x
P/S RatioIs 4531 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4531 income statement (TTM) | |
|---|---|
| Revenue | JP¥13.25b |
| Cost of Revenue | JP¥10.03b |
| Gross Profit | JP¥3.23b |
| Other Expenses | JP¥2.40b |
| Earnings | JP¥828.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 31, 2024
| Earnings per share (EPS) | 38.27 |
| Gross Margin | 24.33% |
| Net Profit Margin | 6.25% |
| Debt/Equity Ratio | 50.1% |
How did 4531 perform over the long term?
See historical performance and comparison